[10] Within a year after stopping treatment with tirzepatide for obesity, people on average regain more than half the weight they lost during treatment, [25] [26] and return to their previous weight within a year and a half
External resources Physiology of the Weight Loss Plateau after GLP-1 Receptor Agonism - PMC Tolerance Does Not Develop Toward Liraglutide Glucose-Lowering Effect - JCEM For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M (2005) Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia
1.5% and 1.6% vs 0.9%
Diagnosis of leptomeningeal metastasis in women with breast cancer through identification of tumor cells in cerebrospinal fluid using the CNSide Assay
For active adults already on IV nutrient therapy or working through a GLP-1 protocol, BPC-157s anti-inflammatory and recovery properties can be complementary